The global market for Torasemide API is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Torasemide API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Torasemide API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Torasemide API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Torasemide API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Torasemide API players cover Zhejiang Huahai Pharmaceutical, Hubei Biocause Heilen Pharmaceutical, Nuray Chemicals, Zeon Health Industries and Teva API, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Torasemide API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Torasemide API market, with both quantitative and qualitative data, to help readers understand how the Torasemide API market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Tons.
Market Segmentation:
The study segments the Torasemide API market and forecasts the market size by Purity (0.98, 0.99 and Others), by Application (Injections, Tablets, Capsules and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by purity
0.98
0.99
Others
Segmentation by application
Injections
Tablets
Capsules
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Zhejiang Huahai Pharmaceutical
Hubei Biocause Heilen Pharmaceutical
Nuray Chemicals
Zeon Health Industries
Teva API
Apotex Pharmachem
Aspire Lifesciences
Aurobindo Pharma
Boryung Pharmaceutical
JARI Pharmaceutical
Kalintis Healthcare
Sanochemia Pharmazeutika GmbH
Vaishali Pharma
Chapter Introduction
Chapter 1: Scope of Torasemide API, Research Methodology, etc.
Chapter 2: Executive Summary, global Torasemide API market size (sales and revenue) and CAGR, Torasemide API market size by region, by purity, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Torasemide API sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Torasemide API sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by purity, and purity.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Torasemide API market size forecast by region, by country, by purity, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Zhejiang Huahai Pharmaceutical, Hubei Biocause Heilen Pharmaceutical, Nuray Chemicals, Zeon Health Industries, Teva API, Apotex Pharmachem, Aspire Lifesciences, Aurobindo Pharma and Boryung Pharmaceutical, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Torasemide API Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Torasemide API by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Torasemide API by Country/Region, 2017, 2022 & 2028
2.2 Torasemide API Segment by Purity
2.2.1 0.98
2.2.2 0.99
2.2.3 Others
2.3 Torasemide API Sales by Purity
2.3.1 Global Torasemide API Sales Market Share by Purity (2017-2022)
2.3.2 Global Torasemide API Revenue and Market Share by Purity (2017-2022)
2.3.3 Global Torasemide API Sale Price by Purity (2017-2022)
2.4 Torasemide API Segment by Application
2.4.1 Injections
2.4.2 Tablets
2.4.3 Capsules
2.4.4 Others
2.5 Torasemide API Sales by Application
2.5.1 Global Torasemide API Sale Market Share by Application (2017-2022)
2.5.2 Global Torasemide API Revenue and Market Share by Application (2017-2022)
2.5.3 Global Torasemide API Sale Price by Application (2017-2022)
3 Global Torasemide API by Company
3.1 Global Torasemide API Breakdown Data by Company
3.1.1 Global Torasemide API Annual Sales by Company (2020-2022)
3.1.2 Global Torasemide API Sales Market Share by Company (2020-2022)
3.2 Global Torasemide API Annual Revenue by Company (2020-2022)
3.2.1 Global Torasemide API Revenue by Company (2020-2022)
3.2.2 Global Torasemide API Revenue Market Share by Company (2020-2022)
3.3 Global Torasemide API Sale Price by Company
3.4 Key Manufacturers Torasemide API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Torasemide API Product Location Distribution
3.4.2 Players Torasemide API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Torasemide API by Geographic Region
4.1 World Historic Torasemide API Market Size by Geographic Region (2017-2022)
4.1.1 Global Torasemide API Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Torasemide API Annual Revenue by Geographic Region
4.2 World Historic Torasemide API Market Size by Country/Region (2017-2022)
4.2.1 Global Torasemide API Annual Sales by Country/Region (2017-2022)
4.2.2 Global Torasemide API Annual Revenue by Country/Region
4.3 Americas Torasemide API Sales Growth
4.4 APAC Torasemide API Sales Growth
4.5 Europe Torasemide API Sales Growth
4.6 Middle East & Africa Torasemide API Sales Growth
5 Americas
5.1 Americas Torasemide API Sales by Country
5.1.1 Americas Torasemide API Sales by Country (2017-2022)
5.1.2 Americas Torasemide API Revenue by Country (2017-2022)
5.2 Americas Torasemide API Sales by Purity
5.3 Americas Torasemide API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Torasemide API Sales by Region
6.1.1 APAC Torasemide API Sales by Region (2017-2022)
6.1.2 APAC Torasemide API Revenue by Region (2017-2022)
6.2 APAC Torasemide API Sales by Purity
6.3 APAC Torasemide API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Torasemide API by Country
7.1.1 Europe Torasemide API Sales by Country (2017-2022)
7.1.2 Europe Torasemide API Revenue by Country (2017-2022)
7.2 Europe Torasemide API Sales by Purity
7.3 Europe Torasemide API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Torasemide API by Country
8.1.1 Middle East & Africa Torasemide API Sales by Country (2017-2022)
8.1.2 Middle East & Africa Torasemide API Revenue by Country (2017-2022)
8.2 Middle East & Africa Torasemide API Sales by Purity
8.3 Middle East & Africa Torasemide API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Torasemide API
10.3 Manufacturing Process Analysis of Torasemide API
10.4 Industry Chain Structure of Torasemide API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Torasemide API Distributors
11.3 Torasemide API Customer
12 World Forecast Review for Torasemide API by Geographic Region
12.1 Global Torasemide API Market Size Forecast by Region
12.1.1 Global Torasemide API Forecast by Region (2023-2028)
12.1.2 Global Torasemide API Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Torasemide API Forecast by Purity
12.7 Global Torasemide API Forecast by Application
13 Key Players Analysis
13.1 Zhejiang Huahai Pharmaceutical
13.1.1 Zhejiang Huahai Pharmaceutical Company Information
13.1.2 Zhejiang Huahai Pharmaceutical Torasemide API Product Offered
13.1.3 Zhejiang Huahai Pharmaceutical Torasemide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Zhejiang Huahai Pharmaceutical Main Business Overview
13.1.5 Zhejiang Huahai Pharmaceutical Latest Developments
13.2 Hubei Biocause Heilen Pharmaceutical
13.2.1 Hubei Biocause Heilen Pharmaceutical Company Information
13.2.2 Hubei Biocause Heilen Pharmaceutical Torasemide API Product Offered
13.2.3 Hubei Biocause Heilen Pharmaceutical Torasemide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Hubei Biocause Heilen Pharmaceutical Main Business Overview
13.2.5 Hubei Biocause Heilen Pharmaceutical Latest Developments
13.3 Nuray Chemicals
13.3.1 Nuray Chemicals Company Information
13.3.2 Nuray Chemicals Torasemide API Product Offered
13.3.3 Nuray Chemicals Torasemide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Nuray Chemicals Main Business Overview
13.3.5 Nuray Chemicals Latest Developments
13.4 Zeon Health Industries
13.4.1 Zeon Health Industries Company Information
13.4.2 Zeon Health Industries Torasemide API Product Offered
13.4.3 Zeon Health Industries Torasemide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Zeon Health Industries Main Business Overview
13.4.5 Zeon Health Industries Latest Developments
13.5 Teva API
13.5.1 Teva API Company Information
13.5.2 Teva API Torasemide API Product Offered
13.5.3 Teva API Torasemide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Teva API Main Business Overview
13.5.5 Teva API Latest Developments
13.6 Apotex Pharmachem
13.6.1 Apotex Pharmachem Company Information
13.6.2 Apotex Pharmachem Torasemide API Product Offered
13.6.3 Apotex Pharmachem Torasemide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Apotex Pharmachem Main Business Overview
13.6.5 Apotex Pharmachem Latest Developments
13.7 Aspire Lifesciences
13.7.1 Aspire Lifesciences Company Information
13.7.2 Aspire Lifesciences Torasemide API Product Offered
13.7.3 Aspire Lifesciences Torasemide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Aspire Lifesciences Main Business Overview
13.7.5 Aspire Lifesciences Latest Developments
13.8 Aurobindo Pharma
13.8.1 Aurobindo Pharma Company Information
13.8.2 Aurobindo Pharma Torasemide API Product Offered
13.8.3 Aurobindo Pharma Torasemide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Aurobindo Pharma Main Business Overview
13.8.5 Aurobindo Pharma Latest Developments
13.9 Boryung Pharmaceutical
13.9.1 Boryung Pharmaceutical Company Information
13.9.2 Boryung Pharmaceutical Torasemide API Product Offered
13.9.3 Boryung Pharmaceutical Torasemide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Boryung Pharmaceutical Main Business Overview
13.9.5 Boryung Pharmaceutical Latest Developments
13.10 JARI Pharmaceutical
13.10.1 JARI Pharmaceutical Company Information
13.10.2 JARI Pharmaceutical Torasemide API Product Offered
13.10.3 JARI Pharmaceutical Torasemide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 JARI Pharmaceutical Main Business Overview
13.10.5 JARI Pharmaceutical Latest Developments
13.11 Kalintis Healthcare
13.11.1 Kalintis Healthcare Company Information
13.11.2 Kalintis Healthcare Torasemide API Product Offered
13.11.3 Kalintis Healthcare Torasemide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Kalintis Healthcare Main Business Overview
13.11.5 Kalintis Healthcare Latest Developments
13.12 Sanochemia Pharmazeutika GmbH
13.12.1 Sanochemia Pharmazeutika GmbH Company Information
13.12.2 Sanochemia Pharmazeutika GmbH Torasemide API Product Offered
13.12.3 Sanochemia Pharmazeutika GmbH Torasemide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Sanochemia Pharmazeutika GmbH Main Business Overview
13.12.5 Sanochemia Pharmazeutika GmbH Latest Developments
13.13 Vaishali Pharma
13.13.1 Vaishali Pharma Company Information
13.13.2 Vaishali Pharma Torasemide API Product Offered
13.13.3 Vaishali Pharma Torasemide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Vaishali Pharma Main Business Overview
13.13.5 Vaishali Pharma Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Torasemide API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Torasemide API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 0.98
Table 4. Major Players of 0.99
Table 5. Major Players of Others
Table 6. Global Torasemide API Sales by Purity (2017-2022) & (Tons)
Table 7. Global Torasemide API Sales Market Share by Purity (2017-2022)
Table 8. Global Torasemide API Revenue by Purity (2017-2022) & ($ million)
Table 9. Global Torasemide API Revenue Market Share by Purity (2017-2022)
Table 10. Global Torasemide API Sale Price by Purity (2017-2022) & (US$/Kg)
Table 11. Global Torasemide API Sales by Application (2017-2022) & (Tons)
Table 12. Global Torasemide API Sales Market Share by Application (2017-2022)
Table 13. Global Torasemide API Revenue by Application (2017-2022)
Table 14. Global Torasemide API Revenue Market Share by Application (2017-2022)
Table 15. Global Torasemide API Sale Price by Application (2017-2022) & (US$/Kg)
Table 16. Global Torasemide API Sales by Company (2020-2022) & (Tons)
Table 17. Global Torasemide API Sales Market Share by Company (2020-2022)
Table 18. Global Torasemide API Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Torasemide API Revenue Market Share by Company (2020-2022)
Table 20. Global Torasemide API Sale Price by Company (2020-2022) & (US$/Kg)
Table 21. Key Manufacturers Torasemide API Producing Area Distribution and Sales Area
Table 22. Players Torasemide API Products Offered
Table 23. Torasemide API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Torasemide API Sales by Geographic Region (2017-2022) & (Tons)
Table 27. Global Torasemide API Sales Market Share Geographic Region (2017-2022)
Table 28. Global Torasemide API Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Torasemide API Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Torasemide API Sales by Country/Region (2017-2022) & (Tons)
Table 31. Global Torasemide API Sales Market Share by Country/Region (2017-2022)
Table 32. Global Torasemide API Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Torasemide API Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Torasemide API Sales by Country (2017-2022) & (Tons)
Table 35. Americas Torasemide API Sales Market Share by Country (2017-2022)
Table 36. Americas Torasemide API Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Torasemide API Revenue Market Share by Country (2017-2022)
Table 38. Americas Torasemide API Sales by Type (2017-2022) & (Tons)
Table 39. Americas Torasemide API Sales Market Share by Purity (2017-2022)
Table 40. Americas Torasemide API Sales by Application (2017-2022) & (Tons)
Table 41. Americas Torasemide API Sales Market Share by Application (2017-2022)
Table 42. APAC Torasemide API Sales by Region (2017-2022) & (Tons)
Table 43. APAC Torasemide API Sales Market Share by Region (2017-2022)
Table 44. APAC Torasemide API Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Torasemide API Revenue Market Share by Region (2017-2022)
Table 46. APAC Torasemide API Sales by Purity (2017-2022) & (Tons)
Table 47. APAC Torasemide API Sales Market Share by Purity (2017-2022)
Table 48. APAC Torasemide API Sales by Application (2017-2022) & (Tons)
Table 49. APAC Torasemide API Sales Market Share by Application (2017-2022)
Table 50. Europe Torasemide API Sales by Country (2017-2022) & (Tons)
Table 51. Europe Torasemide API Sales Market Share by Country (2017-2022)
Table 52. Europe Torasemide API Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Torasemide API Revenue Market Share by Country (2017-2022)
Table 54. Europe Torasemide API Sales by Type (2017-2022) & (Tons)
Table 55. Europe Torasemide API Sales Market Share by Purity (2017-2022)
Table 56. Europe Torasemide API Sales by Application (2017-2022) & (Tons)
Table 57. Europe Torasemide API Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Torasemide API Sales by Country (2017-2022) & (Tons)
Table 59. Middle East & Africa Torasemide API Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Torasemide API Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Torasemide API Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Torasemide API Sales by Purity (2017-2022) & (Tons)
Table 63. Middle East & Africa Torasemide API Sales Market Share by Purity (2017-2022)
Table 64. Middle East & Africa Torasemide API Sales by Application (2017-2022) & (Tons)
Table 65. Middle East & Africa Torasemide API Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Torasemide API
Table 67. Key Market Challenges & Risks of Torasemide API
Table 68. Key Industry Trends of Torasemide API
Table 69. Torasemide API Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Torasemide API Distributors List
Table 72. Torasemide API Customer List
Table 73. Global Torasemide API Sales Forecast by Region (2023-2028) & (Tons)
Table 74. Global Torasemide API Sales Market Forecast by Region
Table 75. Global Torasemide API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Torasemide API Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Torasemide API Sales Forecast by Country (2023-2028) & (Tons)
Table 78. Americas Torasemide API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Torasemide API Sales Forecast by Region (2023-2028) & (Tons)
Table 80. APAC Torasemide API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Torasemide API Sales Forecast by Country (2023-2028) & (Tons)
Table 82. Europe Torasemide API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Torasemide API Sales Forecast by Country (2023-2028) & (Tons)
Table 84. Middle East & Africa Torasemide API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Torasemide API Sales Forecast by Purity (2023-2028) & (Tons)
Table 86. Global Torasemide API Sales Market Share Forecast by Purity (2023-2028)
Table 87. Global Torasemide API Revenue Forecast by Purity (2023-2028) & ($ Millions)
Table 88. Global Torasemide API Revenue Market Share Forecast by Purity (2023-2028)
Table 89. Global Torasemide API Sales Forecast by Application (2023-2028) & (Tons)
Table 90. Global Torasemide API Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Torasemide API Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Torasemide API Revenue Market Share Forecast by Application (2023-2028)
Table 93. Zhejiang Huahai Pharmaceutical Basic Information, Torasemide API Manufacturing Base, Sales Area and Its Competitors
Table 94. Zhejiang Huahai Pharmaceutical Torasemide API Product Offered
Table 95. Zhejiang Huahai Pharmaceutical Torasemide API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 96. Zhejiang Huahai Pharmaceutical Main Business
Table 97. Zhejiang Huahai Pharmaceutical Latest Developments
Table 98. Hubei Biocause Heilen Pharmaceutical Basic Information, Torasemide API Manufacturing Base, Sales Area and Its Competitors
Table 99. Hubei Biocause Heilen Pharmaceutical Torasemide API Product Offered
Table 100. Hubei Biocause Heilen Pharmaceutical Torasemide API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 101. Hubei Biocause Heilen Pharmaceutical Main Business
Table 102. Hubei Biocause Heilen Pharmaceutical Latest Developments
Table 103. Nuray Chemicals Basic Information, Torasemide API Manufacturing Base, Sales Area and Its Competitors
Table 104. Nuray Chemicals Torasemide API Product Offered
Table 105. Nuray Chemicals Torasemide API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 106. Nuray Chemicals Main Business
Table 107. Nuray Chemicals Latest Developments
Table 108. Zeon Health Industries Basic Information, Torasemide API Manufacturing Base, Sales Area and Its Competitors
Table 109. Zeon Health Industries Torasemide API Product Offered
Table 110. Zeon Health Industries Torasemide API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 111. Zeon Health Industries Main Business
Table 112. Zeon Health Industries Latest Developments
Table 113. Teva API Basic Information, Torasemide API Manufacturing Base, Sales Area and Its Competitors
Table 114. Teva API Torasemide API Product Offered
Table 115. Teva API Torasemide API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 116. Teva API Main Business
Table 117. Teva API Latest Developments
Table 118. Apotex Pharmachem Basic Information, Torasemide API Manufacturing Base, Sales Area and Its Competitors
Table 119. Apotex Pharmachem Torasemide API Product Offered
Table 120. Apotex Pharmachem Torasemide API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 121. Apotex Pharmachem Main Business
Table 122. Apotex Pharmachem Latest Developments
Table 123. Aspire Lifesciences Basic Information, Torasemide API Manufacturing Base, Sales Area and Its Competitors
Table 124. Aspire Lifesciences Torasemide API Product Offered
Table 125. Aspire Lifesciences Torasemide API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 126. Aspire Lifesciences Main Business
Table 127. Aspire Lifesciences Latest Developments
Table 128. Aurobindo Pharma Basic Information, Torasemide API Manufacturing Base, Sales Area and Its Competitors
Table 129. Aurobindo Pharma Torasemide API Product Offered
Table 130. Aurobindo Pharma Torasemide API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 131. Aurobindo Pharma Main Business
Table 132. Aurobindo Pharma Latest Developments
Table 133. Boryung Pharmaceutical Basic Information, Torasemide API Manufacturing Base, Sales Area and Its Competitors
Table 134. Boryung Pharmaceutical Torasemide API Product Offered
Table 135. Boryung Pharmaceutical Torasemide API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 136. Boryung Pharmaceutical Main Business
Table 137. Boryung Pharmaceutical Latest Developments
Table 138. JARI Pharmaceutical Basic Information, Torasemide API Manufacturing Base, Sales Area and Its Competitors
Table 139. JARI Pharmaceutical Torasemide API Product Offered
Table 140. JARI Pharmaceutical Torasemide API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 141. JARI Pharmaceutical Main Business
Table 142. JARI Pharmaceutical Latest Developments
Table 143. Kalintis Healthcare Basic Information, Torasemide API Manufacturing Base, Sales Area and Its Competitors
Table 144. Kalintis Healthcare Torasemide API Product Offered
Table 145. Kalintis Healthcare Torasemide API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 146. Kalintis Healthcare Main Business
Table 147. Kalintis Healthcare Latest Developments
Table 148. Sanochemia Pharmazeutika GmbH Basic Information, Torasemide API Manufacturing Base, Sales Area and Its Competitors
Table 149. Sanochemia Pharmazeutika GmbH Torasemide API Product Offered
Table 150. Sanochemia Pharmazeutika GmbH Torasemide API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 151. Sanochemia Pharmazeutika GmbH Main Business
Table 152. Sanochemia Pharmazeutika GmbH Latest Developments
Table 153. Vaishali Pharma Basic Information, Torasemide API Manufacturing Base, Sales Area and Its Competitors
Table 154. Vaishali Pharma Torasemide API Product Offered
Table 155. Vaishali Pharma Torasemide API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 156. Vaishali Pharma Main Business
Table 157. Vaishali Pharma Latest Developments
List of Figures
Figure 1. Picture of Torasemide API
Figure 2. Torasemide API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Torasemide API Sales Growth Rate 2017-2028 (Tons)
Figure 7. Global Torasemide API Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Torasemide API Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 0.98
Figure 10. Product Picture of 0.99
Figure 11. Product Picture of Others
Figure 12. Global Torasemide API Sales Market Share by Purity in 2021
Figure 13. Global Torasemide API Revenue Market Share by Purity (2017-2022)
Figure 14. Torasemide API Consumed in Injections
Figure 15. Global Torasemide API Market: Injections (2017-2022) & (Tons)
Figure 16. Torasemide API Consumed in Tablets
Figure 17. Global Torasemide API Market: Tablets (2017-2022) & (Tons)
Figure 18. Torasemide API Consumed in Capsules
Figure 19. Global Torasemide API Market: Capsules (2017-2022) & (Tons)
Figure 20. Torasemide API Consumed in Others
Figure 21. Global Torasemide API Market: Others (2017-2022) & (Tons)
Figure 22. Global Torasemide API Sales Market Share by Application (2017-2022)
Figure 23. Global Torasemide API Revenue Market Share by Application in 2021
Figure 24. Torasemide API Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Torasemide API Revenue Market Share by Company in 2021
Figure 26. Global Torasemide API Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Torasemide API Revenue Market Share by Geographic Region in 2021
Figure 28. Global Torasemide API Sales Market Share by Region (2017-2022)
Figure 29. Global Torasemide API Revenue Market Share by Country/Region in 2021
Figure 30. Americas Torasemide API Sales 2017-2022 (Tons)
Figure 31. Americas Torasemide API Revenue 2017-2022 ($ Millions)
Figure 32. APAC Torasemide API Sales 2017-2022 (Tons)
Figure 33. APAC Torasemide API Revenue 2017-2022 ($ Millions)
Figure 34. Europe Torasemide API Sales 2017-2022 (Tons)
Figure 35. Europe Torasemide API Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Torasemide API Sales 2017-2022 (Tons)
Figure 37. Middle East & Africa Torasemide API Revenue 2017-2022 ($ Millions)
Figure 38. Americas Torasemide API Sales Market Share by Country in 2021
Figure 39. Americas Torasemide API Revenue Market Share by Country in 2021
Figure 40. United States Torasemide API Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Torasemide API Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Torasemide API Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Torasemide API Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Torasemide API Sales Market Share by Region in 2021
Figure 45. APAC Torasemide API Revenue Market Share by Regions in 2021
Figure 46. China Torasemide API Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Torasemide API Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Torasemide API Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Torasemide API Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Torasemide API Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Torasemide API Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Torasemide API Sales Market Share by Country in 2021
Figure 53. Europe Torasemide API Revenue Market Share by Country in 2021
Figure 54. Germany Torasemide API Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Torasemide API Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Torasemide API Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Torasemide API Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Torasemide API Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Torasemide API Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Torasemide API Revenue Market Share by Country in 2021
Figure 61. Egypt Torasemide API Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Torasemide API Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Torasemide API Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Torasemide API Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Torasemide API Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Torasemide API in 2021
Figure 67. Manufacturing Process Analysis of Torasemide API
Figure 68. Industry Chain Structure of Torasemide API
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Global Graphitized Carbon Black (GCB) Ma..
Graphitized carbon black is a black particle that can be use..
+16467917070US (Toll Free)